CBUS Stock Analysis: Buy, Sell, or Hold?
CBUS - Cibus, Inc. Class A Common Stock
$1.95
0.03 (1.56%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When CBUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CBUS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CBUS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CBUS is currently trading at $1.95, which is considered slightly high relative to its 30-day fair value range of $1.63 to $2.06.
Technical Outlook: Technically, CBUS is in a uptrend. Immediate support is located at $1.46, while resistance sits at $2.04.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.47 (+653.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CBUS is in a uptrend. Immediate support is located at $1.46, while resistance sits at $2.04.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.47 (+653.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$1.63 -
$2.06
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 653.9% below Wall St target ($14.47)
Fair Price Analysis
30-Day Fair Range
$1.63 -
$2.06
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.46
Resistance Level
$2.04
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.61
Wall Street Target
$14.48
(+653.9%)
Revenue Growth (YoY)
-63.1%
Last updated: January 30, 2026 10:53 PM ET
Data refreshes hourly during market hours. Next update: 11:53 PM
Data refreshes hourly during market hours. Next update: 11:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced CBUS Option Strategies
Professional options setups generated by AI based on today's CBUS price and gamma walls.
